/Lilly(Eli)%20%26%20Co%20logo%20on%20building-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) researches, develops, and markets medicines across cardiometabolic disease, oncology, immunology, neuroscience, and beyond.
With a market capitalization of nearly $952.3 billion, it occupies “mega-cap” territory, an exclusive club reserved for companies valued above $200 billion. The scale allows the company to bankroll innovation, fortify global partnerships, and strengthen licensing alliances that keep its pipeline both deep and defensible.